Showing 1 - 20 results of 35 for search 'Jean Yves Pierga', query time: 0.06s
Refine Results
-
1
Clinical utility of circulating tumor cells: an update by Antoine Vasseur, Nicolas Kiavue, François‐Clément Bidard, Jean‐Yves Pierga, Luc Cabel
Published 2021-06-01
Article -
2
-
3
-
4
-
5
PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Pacl... by Alexandre Bertucci, François Bertucci, François Bertucci, François Bertucci, Christophe Zemmour, Florence Lerebours, Jean-Yves Pierga, Jean-Yves Pierga, Christelle Levy, Florence Dalenc, Julien Grenier, Thierry Petit, Marguerite Berline, Anthony Gonçalves, Anthony Gonçalves, Anthony Gonçalves, Anthony Gonçalves
Published 2020-11-01
Article -
6
-
7
-
8
-
9
Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study by François-Clément Bidard, Lisa Belin, Suzette Delaloge, Florence Lerebours, Charlotte Ngo, Fabien Reyal, Séverine Alran, Sylvie Giacchetti, Michel Marty, Ronald Lebofsky, Jean-Yves Pierga
Published 2013-01-01
Article -
10
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Me... by Anne Brédart, Aude Rault, Johanna Terrasson, Etienne Seigneur, Leanne De Koning, Elisabeth Hess, Alexia Savignoni, Paul Cottu, Jean-Yves Pierga, Sophie Piperno-Neumann, Manuel Rodrigues, Carole Bouleuc, Sylvie Dolbeault
Published 2022-01-01
Article -
11
Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma. by Fabien Reyal, Marc A Bollet, Martial Caly, David Gentien, Sabrina Carpentier, Hélène Peyro-Saint-Paul, Jean-Yves Pierga, Paul Cottu, Véronique Dieras, Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Xavier Sastre-Garau
Published 2012-01-01
Article -
12
Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma. by Fabien Reyal, Marc A. Bollet, Martial Caly, David Gentien, Sabrina Carpentier, Hélène Peyro-Saint-Paul, Jean-Yves Pierga, Paul Cottu, Véronique Dieras, Brigitte Sigal-Zafrani, Anne Vincent-Salomon, Xavier Sastre-Garau
Published 2012-01-01
Article -
13
Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. by Hélène Bonsang-Kitzis, Léonor Chaltier, Lisa Belin, Alexia Savignoni, Roman Rouzier, Marie-Paule Sablin, Florence Lerebours, François-Clément Bidard, Paul Cottu, Xavier Sastre-Garau, Marick Laé, Jean-Yves Pierga, Fabien Reyal
Published 2015-01-01
Article -
14
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer. by Sjoerd T Ligthart, Frank A W Coumans, Francois-Clement Bidard, Lieke H J Simkens, Cornelis J A Punt, Marco R de Groot, Gerhardt Attard, Johann S de Bono, Jean-Yves Pierga, Leon W M M Terstappen
Published 2013-01-01
Article -
15
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers by Florentine S. Hilbers, Coralie Poncet, Konstantinos Tryfonidis, Giuseppe Viale, Suzette Delaloge, Jean-Yves Pierga, Etienne G. C. Brain, Isabel T. Rubio, Alastair M. Thompson, Emiel J. T. Rutgers, Martine J. Piccart, Laura J. van ’t Veer, Fatima Cardoso
Published 2024-11-01
Article -
16
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. by Hélène Bonsang-Kitzis, Léonor Chaltier, Lisa Belin, Alexia Savignoni, Roman Rouzier, Anne-Sophie Hamy, Marie-Paule Sablin, Florence Lerebours, François-Clément Bidard, Paul Cottu, Xavier Sastre-Garau, Marick Laé, Jean-Yves Pierga, Fabien Reyal
Published 2016-01-01
Article -
17
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients by Lauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, Ivan Bièche, Amanda Bartolini Silveira, Marc Michel, Delphine Loirat, Paul Cottu, Luc Cabel, Coraline Dubot, Romain Geiss, Francesco Ricci, Anne Vincent-Salomon, Charlotte Proudhon, François-Clément Bidard
Published 2021-03-01
Article -
18
External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement. by David Hajage, Yann de Rycke, Marc Bollet, Alexia Savignoni, Martial Caly, Jean-Yves Pierga, Hugo M Horlings, Marc J Van de Vijver, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, Claire Senechal, Bernard Asselain, Xavier Sastre, Fabien Reyal
Published 2011-01-01
Article -
19
The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma. by Fabien Reyal, Roman Rouzier, Berenice Depont-Hazelzet, Marc A Bollet, Jean-Yves Pierga, Severine Alran, Remy J Salmon, Virginie Fourchotte, Anne Vincent-Salomon, Xavier Sastre-Garau, Martine Antoine, Serge Uzan, Brigitte Sigal-Zafrani, Yann De Rycke
Published 2011-01-01
Article -
20
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy. by Anne-Sophie Hamy, Lauren Darrigues, Enora Laas, Diane De Croze, Lucian Topciu, Giang-Thanh Lam, Clemence Evrevin, Sonia Rozette, Lucie Laot, Florence Lerebours, Jean-Yves Pierga, Marie Osdoit, Matthieu Faron, Jean-Guillaume Feron, Marick Laé, Fabien Reyal
Published 2020-01-01
Article